Covishield is less expensive compared to some of the other vaccines being used — such as the ones from Pfizer-BioNTech and Moderna.
from The Hindu - National https://ift.tt/37GjPGn
via alochona
Wednesday, February 24, 2021
Home »
» Tie-up with Serum Institute of India key to mass production of COVID vaccines, say two pharma majors
0 comments:
Post a Comment